obtained a bachelor degree in Molecular Biology from the University of Surrey and a Masters qualification in Molecular Biology, Biochemistry and Genetic Manipulation from the University of Sussex. She went on to obtain a second Masters degree in Preimplantation Genetics and Fetal Medicine from University College London, followed by a PhD in human genetics. After completing her studies she performed clinical diagnostics at the UCL Centre for PGD and carried out research into the cytogenetics of human oocytes. She later moved to the United States of America, taking a research position at Yale University Medical School. In 2007 she returned to the UK, and worked as the Lab Director at Repogenetics UK as well as holding a research position at the University of Oxford. She recently became the Scientific Director of Reprogenetics UK.
Elpida played a key role in the development, validation, and clinical application of comparative genomic hybridisation (CGH), the first comprehensive chromosome analysis method to be widely applied to the study of human embryos. The proliferation of chromosome screening techniques seen during the last few years owes much to the Elpida’s early work in this area. Of particular note are her studies that highlighted the blastocyst as the optimal stage for aneuploidy screening to be undertaken. Her work has led to the most detailed characterization of chromosome abnormalities in human oocytes published to date.
Elpida’s current research interests focus on understanding the mechanisms leading to aneuploidy, and developing methods for the non-invasive and invasive assessment of gametes and embryos. She has published more than 30 peer-reviewed papers and book chapters and has been the recipient of multiple awards for her work, including the New England Fertility Society-PCRS Exchange Prize for best submitted abstract (2007) awarded for her work on CGH, the ESHRE Basic Science Prize (2011) for her study of the transcriptome of cumulus cells, and the ASRM SART (2015) Prize for the assessment of the mitochondrial genome of human embryos. Elpida is a familiar figure at international scientific and medical conferences, her cutting-edge work frequently leading to invitations to speak.
Elpida feels strongly about the need to improve the accuracy and efficacy of preimplantation genetic diagnosis (PGD). She also has a strong commitment to teaching and the sharing of scientific knowledge. Towards this end she spent several years spent on the Editorial Board of various scientific journals such as Human Reproduction, Molecular Human Reproduction, Reproductive Biomedicine Online, and the Journal of Assisted Reproduction and Genetics, and teaches and supervises postgraduate students at the University of Oxford.